FDA probes suicide risk in Merck Singulair
WASHINGTON (Reuters) - U.S. health regulators are probing a possible connection between Merck & Co's Singulair asthma drug and suicidal behavior, the Food and Drug Administration said on Thursday.
27 march 2008 25 results of this feed other results in this category